Q fever during pregnancy: A cause of poor fetal and maternal outcome

Annals of the New York Academy of Sciences

Volumn 1166, Issue , 2009, Pages 79-89

  Carcopino, Xavier ^a,b   Raoult, Didier ^b   Bretelle, Florence ^a   Boubli, Léon ^a   Stein, Andreas ^b  

^a HÔPITAL NORD   (France)

^b CNRS   (France)

Author keywords

Coxiella burnetii; Pregnancy; Q fever; Stillbirth; Trimethoprim Sulfamethoxazole combination

Indexed keywords

CHLOROQUINE; COTRIMOXAZOLE; DOXYCYCLINE; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M; LIVER ENZYME; Q FEVER VACCINE; Q VAX; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TETRACYCLINE DERIVATIVE; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ACUTE DISEASE; ADVERSE OUTCOME; AGE DISTRIBUTION; AMPHIBIA; ANEURYSM; ARTHROPOD; ARTICLE; BACTERIAL VIRULENCE; BACTERICIDAL ACTIVITY; BACTERIOSTASIS; BACTERIUM IDENTIFICATION; BIRD; BLOOD VESSEL PROSTHESIS; CATTLE; CELL CULTURE; CHRONIC DISEASE; CONTAMINATION; COXIELLA BURNETII; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; DISEASE CARRIER; DISEASE SEVERITY; DRUG EFFICACY; ENDOCARDITIS; ENZYME BLOOD LEVEL; EPIDEMIOLOGICAL DATA; EUROPE; FARM ANIMAL; FETUS; FETUS DEATH; FETUS MORTALITY; FETUS OUTCOME; FEVER; FISH; FOLLOW UP; GLOVE; GOAT; HEART MURMUR; HEMODIALYSIS; HEPATITIS; HEPATITIS B; HERPES; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HYPERBILIRUBINEMIA; IMMUNE DEFICIENCY; IMMUNITY; IMMUNOCOMPROMISED PATIENT; IMMUNOFLUORESCENCE; IMMUNOGLOBULIN BLOOD LEVEL; IN VITRO STUDY; INFECTION RISK; INJECTION SITE REACTION; INTRAUTERINE GROWTH RETARDATION; INTRAUTERINE INFECTION; LEUKOCYTE COUNT; LISTERIOSIS; LONG TERM CARE; MAMMAL; MASK; MATERNAL WELFARE; MORBIDITY; MORTALITY; NEW ZEALAND; NONHUMAN; OLIGOHYDRAMNIOS; PHAGOLYSOSOME; PHOTOSENSITIVITY; PLACENTA; PLACENTA DISORDER; PLACENTAL INFECTION; PLACENTITIS; PNEUMONIA; POLYMERASE CHAIN REACTION; PREGNANCY; PREGNANT WOMAN; PREMATURE LABOR; Q FEVER; RUBELLA; SCREENING; SEROLOGY; SEX DIFFERENCE; SHEEP; SINGLE DRUG DOSE; SPONTANEOUS ABORTION; SPRING; STILLBIRTH; SUMMER; THROMBOCYTOPENIA; TOXOPLASMA; VALVULAR HEART DISEASE; VERTICAL TRANSMISSION; VETERINARY MEDICINE; WASTE MANAGEMENT; ZOONOSIS;

BACTERIA (MICROORGANISMS); COXIELLA BURNETII;

EID: 67649713492     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.04519.x     Document Type: Article

References (115)

1. Derrick, E. 1937. "Q" fever, a new fever entity: clinical features, diagnosis and laboratory investigation. Med. J. Aust. 2: 281-289.
2. Davis, G.E. & H.R. Cox. 1938. A filter-passing infectious agent isolated from ticks. I. Isolation from Dermacentor andersoni, reactions in animals, and filtration experiments. Public Health Rep. 54: 2259- 2267.
3. McDade, J.E. 1990. Historical aspects of Q fever. Q Fever, the Disease. T. Marrie, Ed.: 6-21. CRC Press. Boca Raton.
4. Burnet, M. & M. Freeman. 1937. Experimental studies on the virus of "Q" fever. Med. J. Aust. 2: 299-305.
5. Parker, N.R., J.H. Barralet & A.M. Bell. 2006. Q Fever Lancet 367: 679-688.
6. Tissot-Dupont, H. et al. 2007. Role of sex, age, previous valve lesion, and pregnancy in the clinical expression and outcome of Q fever after a large outbreak. Clin. Infect Dis. 44: 232-237.
7. Tissot-Dupont, H. et al. 2004. Wind in November, Q fever in December. Emerg. Infect. Dis. 10: 1264- 1269.
8. de los Rios-Martin, R. et al. 2006. Q fever outbreak in an urban area following a school-farm visit. Med. Clin. (Barc). 126: 573-575.
9. Starnini, G. et al. 2005. An outbreak of Q fever in a prison in Italy. Epidemiol. Infect. 133: 377-380.
10. Dupuis, G. et al. 1987. An important outbreak of human Q fever in a Swiss Alpine valley. Int. J. Epidemiol. 16: 282-287.
11. van Woerden, H.C. et al. 2004. Q fever outbreak in industrial setting. Emerg. Infect. Dis. 10: 1282-1289.
12. Schneider, T. et al. 1993. A Q fever epidemic in Berlin. The epidemiological and clinical aspects. Dtsch. Med. Wochenschr. 118: 689-695.
13. Oren, I. et al. 2005. An outbreak of Q fever in an urban area in Israel. Eur J. Clin. Microbiol. Infect. Dis. 24: 338-341.
14. Marrie, T.J. 1988. Seroepidemiology of Q fever in New Brunswick and Manitoba. Can. J. Microbiol. 34: 1043-1045.
15. Maurin, M. & D. Raoult. 1999. Q fever. Clin. Microbiol. Rev. 12: 518-553.
16. Raoult, D. et al. 2000. Q fever 1985-1998. Clinical and epidemiologic features of 1,383 infections. Medicine (Baltimore) 79: 109-123.
17. Carcopino, X. et al. 2007. Managing Q fever during pregnancy: the benefits of long-term cotrimoxazole therapy. Clin. Infect Dis. 45: 548-555.
18. Fournier, P.E., T.J. Marrie & D. Raoult. 1998. Diagnosis of Q fever. J. Clin. Microbiol. 36: 1823-1834.
19. Hackstadt, T. & J.C. Williams. 1981. Biochemical stratagem for obligate parasitism of eukaryotic cells by Coxiella burnetii. Proc. Natl. Acad. Sci. USA 78: 3240-3244.
20. Maurin, M. et al. 1992. Phagolysosomes of Coxiella burnetii-infected cell lines maintain an acidic pH during persistent infection. Infect Immun. 60: 5013- 5016.
21. McCaul, T.F. 1991. The developmental cycle of Coxiella burnetii. In Q Fever: The Biology of Coxiella Burnetii. J. Williams & H.A. Thompson, Eds.: 224- 258. CRC Press. Boca Raton.
22. Hackstadt, T. 1990. The role of lipopolysaccharides in the virulence of Coxiella burnetii. Ann. N. Y. Acad. Sci. 590: 27-32.
23. Hackstadt, T. et al. 1985. Lipopolysaccharide variation in Coxiella burnetti: intrastrain heterogeneity in structure and antigenicity. Infect Immun. 48: 359- 365.
24. Hackstadt, T. 1986. Antigenic variation in the phase I lipopolysaccharide of Coxiella burnetii isolates. Infect Immun. 52: 337-340.
25. Toman, R. & J. Kazar. 1991. Evidence for the structural heterogeneity of the polysaccharide component of Coxiella burnetii strain Nine Mile lipopolysaccharide. Acta. Virol. 35: 531-537.
26. Amano, K. & J.C. Williams. 1984. Chemical and immunological characterization of lipopolysaccha-rides from phase I and phase II Coxiella burnetii. J. Bacteriol. 160: 994-1002.
27. Hirai, K. & H. To. 1998. Advances in the understanding of Coxiella burnetii infection in Japan. J. Vet. Med. Sci. 60: 781-790.
28. Lang, G. 1990. Coxiellosis (Q fever) in animals. Q Fever, the Disease. T. Marrie, Ed.: 23-48. CRC Press. Boca Raton.
29. Marrie, T.J., J. Embil & L. Yates. 1993. Seroepi-demiology of Coxiella burnetii among wildlife in Nova Scotia. Am. J. Trop. Med. Hyg. 49: 613-615.
30. Woldehiwet, Z. 2004. Q fever (coxiellosis): epidemiology and pathogenesis. Res. Vet. Sci. 77: 93-100.
31. Higgins, D. & T.J. Marrie. 1990. Seroepidemiology of Q fever among cats in New Brunswick and Prince Edward Island. Ann. N. Y. Acad. Sci. 590: 271-274.
32. Langley, J.M. et al. 1988. Poker player's pneumonia. An urban outbreak of Q fever following exposure to a parturient cat. New Engl. J. Med. 319: 354-356.
33. Marrie, T.J. et al. 1988. Exposure to parturient cats: a risk factor for acquisition of Q fever in Maritime Canada. J. Infect Dis. 158: 101-108.
34. Marrie, T.J. et al. 1988. An outbreak of Q fever probably due to contact with a parturient cat. Chest 93: 98-103.
35. Morita, C. et al. 1994. Seroepidemiological survey of Coxiella burnetii in domestic cats in Japan. Microbiol. Immunol. 38: 1001-1003.
36. Arricau Bouvery, N. et al. 2003. Experimental Coxiella burnetii infection in pregnant goats: excretion routes. Vet. Res. 34: 423-433.
37. Berri, M. et al. 2001. Relationships between the shedding of Coxiella burnetii, clinical signs and sero-logical responses of 34 sheep. Vet. Rec. 148: 502-505.
38. Marrie, T. 1990. Epidemiology of Q fever. Q Fever, the Disease. T. Marrie, Ed.: 49-65. CRC Press. Boca Raton.
39. Stoker, M.G. & B.P. Marmion. 1955. The spread of Q fever from animals to man; the natural history of a rickettsial disease. Bull World Health Organ 13: 781-806.
40. Babudieri, B. 1959. Q fever: a zoonosis. Adv. Vet. Sci. 5: 81-102.
41. McCaul, T.F. & J.C. Williams. 1990. Localization of DNA in Coxiella burnetii by post-embedding im-munoelectron microscopy. Ann. N. Y. Acad. Sci. 590: 136-147.
42. Valero, F. et al. 1995. Pericardial effusion as the initial feature of Q fever. Am. Heart J. 130: 1308- 1309.
43. Hawker, J.I. et al. 1998. A large outbreak of Q fever in the West Midlands: windborne spread into a metropolitan area? Commun Dis Public Health 1: 180-187.
44. Tissot-Dupont, H. et al. 1999. Hyperendemic focus of Q fever related to sheep and wind. Am. J. Epidemiol. 150: 67-74.
45. Fishbein, D.B. & D. Raoult. 1992. A cluster of Cox-iella burnetii infections associated with exposure to vaccinated goats and their unpasteurized dairy products. Am. J. Trop. Med. Hyg. 47: 35-40.
46. Tissot Dupont, H. et al. 1992. Epidemiologic features and clinical presentation of acute Q fever in hospitalized patients: 323 French cases. Am. J. Med. 93: 427-434.
47. Raoult, D. & A. Stein. 1994. Q fever during pregnancy-a risk for women, fetuses and obstetricians. N. Engl. J. Med. 330: 371.
48. Kruszewska, D. & S. Tylewska-Wirzbanowska. 1992. Influence of Coxiella burnetii infection of male mice on their offspring. Acta. Virol. 36: 79-82.
49. Milazzo, A. et al. 2001. Sexually transmitted Q fever. Clin. Infect Dis. 33: 399-402.
50. Mann, J.S. et al. 1986. Q fever: person to person transmission within a family. Thorax 41: 974-975.
51. Ludlam, H. et al. 1997. Q fever in pregnancy. J. Infect. 34: 75-78.
52. Leonetti, F. et al. 1994. Chronic Q fever in hemodial-ysis patients. Nephron 67: 231-233.
53. Raoult, D. 1990. Host factors in the severity of Q fever. Ann. N. Y. Acad. Sci. 590: 33-38.
54. Raoult, D. et al. 1992. Acute and chronic Q fever in patients with cancer. Clin. Infect Dis. 14: 127-130.
55. Heard, S.R., C.J. Ronalds & R.B. Heath. 1985. Cox-iella burnetii infection in immunocompromised patients. J. Infect. 11: 15-18.
56. Loudon, M.M. & E.N. Thompson. 1988. Severe combined immunodeficiency syndrome, tissue transplant, leukaemia, and Q fever. Arch. Dis. Child. 63: 207-209.
57. Larsen, C.P. et al. 2006. Infection in renal transplantation: a case of acute Q fever. Am. J. Kidney Dis. 48: 321-326.
58. Kanfer, E. et al. 1988. Q fever following bone marrow transplantation. Bone Marrow Transplant 3: 165- 166.
59. Kaplan, M.M. & P. Bertagna. 1955. The geographical distribution of Q fever. Bull WHO 13: 829-860.
60. Hilbink, F. et al. 1993. Q fever is absent from New Zealand. Int. J. Epidemiol. 22: 945-949.
61. Greenslade, E. et al. 2003. Has Coxiella burnetii (Q fever) been introduced into New Zealand? Emerg. Infect. Dis. 9: 138-140.
62. Bartlett, J.G. 2000. Questions about Q fever. Medicine (Baltimore) 79: 124-125.
63. Marrie, T.J. & L. Yates. 1990. Incidence of Q fever: pilot studies in two areas in Nova Scotia. Ann. N. Y. Acad. Sci. 590: 275-280.
64. Marrie, T.J. et al. 1984. Seroepidemiology of Q fever in Nova Scotia and Prince Edward Island. Can. J. Microbiol. 30: 129-134.
65. Blondeau, J. et al. 1990. Q fever in Sokoto, Nigeria. Ann. N. Y. Acad. Sci. 590: 281-282.
66. Kelly, P.J. et al. 1993. Q fever in Zimbabwe. A review of the disease and the results of a serosurvey of humans, cattle, goats and dogs. S. Afr. Med. J. 83: 21-25.
67. Langley, J.M. et al. 2003. Coxiella burnetii seropos-itivity in parturient women is associated with adverse pregnancy outcomes. Am. J. Obstet. Gynecol. 189: 228-232.
68. Anstey, N.M. et al. 1997. Seroepidemiology of Rick-ettsia typhi, spotted fever group rickettsiae, and Coxiella burnetti infection in pregnant women from urban Tanzania. Am. J. Trop. Med. Hyg. 57: 187-189.
69. Rey, D. et al. 2000. Seroprevalence of antibodies to Coxiella burnetti among pregnant women in South Eastern France. Eur. J. Obstet. Gynecol. Reprod. Biol. 93: 151-156.
70. Stein, A. & D. Raoult. 1998. Q fever during pregnancy: a public health problem in southern France. Clin. Infect Dis. 27: 592-596.
71. Denis, F., J.L. Tabaste & S. Ranger-Rogez. 1994. Prevalence of HBs Ag in about 21,500 pregnant women. Survey at twelve French University Hospitals. The Muticentric Study Group. Pathol. Biol. (Paris) 42: 533-538.
72. Raoult, D. 2002. Q fever: still a mysterious disease. Qjm 95: 491-492.
73. McQuiston, J.H. & J.E. Childs. 2002. Q fever in humans and animals in the United States. Vector Borne Zoonotic Dis. 2: 179-191.
74. Kermode, M. et al. 2003. An economic evaluation of increased uptake in Q fever vaccination among meat and agricultural industry workers following implementation of the National Q Fever Management Program. Aust. N. Z. J. Public Health 27: 390- 398.
75. Fournier, P.E. et al. 2001. Myocarditis, a rare but severe manifestation of Q fever: report of 8 cases and review of the literature. Clin. Infect Dis. 32: 1440- 14407.
76. Fenollar, F. et al. 2001. Risks factors and prevention of Q fever endocarditis. Clin. Infect Dis. 33: 312-316.
77. Raoult, D., F. Fenollar & A. Stein. 2002. Q fever during pregnancy: diagnosis, treatment, and follow-up. Arch. Intern. Med. 162: 701-704.
78. Raoult, D. & T. Marrie. 1995. Q fever. Clin. Infect Dis. 20: 489-495; quiz 496.
79. Tobin, M.J. et al. 1982. Q fever endocarditis. Am. J. Med. 72: 396-400.
80. Raoult, D. et al. 1993. Q fever and HIV infection. Aids. 7: 81-86.
81. Fenollar, F. et al. 2006. Endocarditis after acute Q fever in patients with previously undiagnosed valvu-lopathies. Clin. Infect Dis. 42: 818-821.
82. Stein, A. & D. Raoult. 1995. Q fever endocarditis. Eur. Heart J. 16(Suppl B): 19-23.
83. Dupont, H.T., X. Thirion & D. Raoult. 1994. Q fever serology: cutoff determination for microim-munofluorescence. Clin. Diagn. Lab. Immunol. 1: 189- 196.
84. Worswick, D. & B.P. Marmion. 1985. Antibody responses in acute and chronic Q fever and in subjects vaccinated against Q fever. J. Med. Microbiol. 19: 281-296.
85. Stein, A. & D. Raoult. 1992. Detection of Coxiella burnetti by DNA amplification using polymerase chain reaction. J. Clin. Microbiol. 30: 2462-2466.
86. Stein, A. et al. 2000. Repeated pregnancies in BALB/c mice infected with Coxiella burnetii cause disseminated infection, resulting in stillbirth and endocarditis. J. Infect Dis. 181: 188-194.
87. Parker, R.R., E.J. Bell & D.B. Lackman. 1948. Experimental studies of Q fever in cattle: I. Observations on four heifers and two milk cows. Am. J. Hyg. 48: 191-197.
88. Luoto, L. & R.J. Huebner. 1950. Q fever studies in southern California; IX. Isolation of Q fever organisms from parturient placenta; of naturally infected dairy cows. Public Health Rep. 65: 541-544.
89. Abinanti, F.R. et al. 1953. Q fever studies. XVIII. Presence of Coxiella burnetii in the birth fluids of naturally infected sheep. Am. J. Hyg. 58: 385- 388.
90. Waldhalm, D.G. et al. 1978. Abortion associated with Coxiella burnetii infection in dairy goats. J. Am. Vet. Med. Assoc. 173: 1580-1581.
91. Stoker, M.G. & J.F. Thompson. 1953. An explosive outbreak of Q fever. Lancet 1: 137-139.
92. Stoenner, H.G. 1951. Experimental Q fever in cattle-epizootiologic aspects. J. Am. Vet. Med. Assoc. 118: 170-174.
93. Palmer, N.C. et al. 1983. Placentitis and Abortion in Goats and Sheep in Ontario Caused by Coxiella burnetii. Can. Vet. J. 24: 60-61.
94. Berri, M. et al. 2007. Goats may experience reproductive failures and shed Coxiella burnetii at two successive parturitions after a Q fever infection. Res.Vet. Sci. 83: 47-52.
95. Kaplan, B. et al. 1995. An isolated case of Q-fever during pregnancy. Acta. Obstet. Gynecol. Scand. 74: 848-849.
96. Gaburro, D. & A. Del Campo. 1956. Consider-azioni epidemiologiche e cliniche su un' infezione de Coxiella burnetii in tre gemelle immature. Mal. Inf. Parsit. 8: 384.
97. Tellez, A. et al. 1998. Q fever in pregnancy: case report after a 2-year follow-up. J. Infect. 37: 79-81.
98. Syrucek, L., O. Sobeslavsky & I. Gutvirth. 1958. Isolation of Coxiella burneti from human placentas. J. Hyg. Epidemiol. Microbiol. Immunol. 2: 29-35.
99. Riechman, N. et al. 1988. Chronic Q fever and severe thrombocytopenia in a pregnant woman. Am. J. Med. 85: 253-254.
100. McGivern, D. et al. 1988. Concomitant zoonotic infections with ovine Chlamydia and 'Q' fever in pregnancy: clinical features, diagnosis, management and public health implications. Case report. Br. J. Obstet. Gynaecol. 95: 294-298.
101. Marrie, T.J. 1993. Q fever in pregnancy: report of two cases. Infect. Dis. Clin. Pract. 2: 207-209.
102. Jover-Diaz, F. et al. 2001. Q fever during pregnancy: an emerging cause of prematurity and abortion. Infect Dis. Obstet. Gynecol. 9: 47-49.
103. Hellmeyer, L. et al. 2002. Q Fever in pregnancy: a case report and review of the literature. Z Geburtshilfe Neonatol. 206: 193-198.
104. Friedland, J.S. et al. 1994. Q fever and intrauterine death. Lancet 343: 288.
105. Ellis, M.E., C.C. Smith & M.A. Moffat. 1983. Chronic or fatal Q-fever infection: a review of 16 patients seen in North-East Scotland (1967-80). Q. J. Med. 52: 54-66.
106. Dindinaud, G. et al. 1991. Q fever and fetal death in utero. Two cases. J. Gynecol. Obstet. Biol. Reprod. (Paris) 20: 969-972.
107. Bental, T. et al. 1995. Chronic Q fever of pregnancy presenting as Coxiella burnetii placentitis: successful outcome following therapy with ery-thromycin and rifampin. Clin. Infect Dis. 21: 1318- 1321.
108. Wagstaff, D.F. et al. 1959. Q fever studies in Maryland. Public Health Rep. 80: 1095-1099.
109. Raoult, D. 1993. Treatment of Q fever. Antimicrob Agents Chemother. 37: 1733-1736.
110. Maurin, M. et al. 1992. Phagolysosomal alkaliniza-tion and the bactericidal effect of antibiotics: the Coxiella burnetii paradigm. J. Infect Dis. 166: 1097- 1102.
111. Raoult, D. et al. 1999. Treatment of Q fever endo-carditis: comparison of 2 regimens containing doxy-cycline and ofloxacin or hydroxychloroquine. Arch. Intern. Med. 159: 167-173.
112. Lim, W.S., J.T. Macfarlane & C.L. Colthorpe. 2003. Treatment of community-acquired lower respiratory tract infections during pregnancy. Am. J. Respir. Med. 2: 221-233.
113. Marmion, B.P. et al. 1990. Vaccine prophylaxis of abattoir-associated Q fever: eight years' experience in Australian abattoirs. Epidemiol. Infect. 104: 275- 287.
114. Ormsbee, R. & B. Marmion. 1990. Prevention of Coxiella burnetii infection: vaccines and guidelines for those at risk. In Q Fever, the Disease. T.J. Marrie, Ed.: 226-248. CRC Press. Boca Raton.
115. Ackland, J.R., D.A. Worswick & B.P. Marmion. 1994. Vaccine prophylaxis of Q fever. A follow-up study of the efficacy of Q-Vax (CSL) 1985-1990. Med. J. Aust. 160: 704-708.